Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) -482C>T polymorphism on triglyceride concentration in Turkish adults.

Coban N, Onat A, Guclu-Geyik F, Komurcu-Bayrak E, Sansoy V, Hergenc G, Can G, Erginel-Unaltuna N.

Clin Chem Lab Med. 2011 Oct 18;50(2):285-92. doi: 10.1515/CCLM.2011.747.

PMID:
22004016
2.

Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.

Onat A, Hergenç G, Can G, Uğur M, Nartop F.

Clin Chem Lab Med. 2011 Aug;49(8):1349-57. doi: 10.1515/CCLM.2011.110. Epub 2011 Jul 14.

PMID:
21756164
3.

Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.

Onat A, Can G, Hergenç G, Uğur M, Yüksel H.

Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):643-50. doi: 10.1016/j.numecd.2010.10.010. Epub 2011 Feb 11.

PMID:
21315565
4.

Obstructive sleep apnea and type 2 diabetes.

Rasche K, Keller T, Tautz B, Hader C, Hergenc G, Antosiewicz J, Di Giulio C, Pokorski M.

Eur J Med Res. 2010 Nov 4;15 Suppl 2:152-6. Review.

5.

"Atherogenic index of plasma" (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events.

Onat A, Can G, Kaya H, Hergenç G.

J Clin Lipidol. 2010 Mar-Apr;4(2):89-98. doi: 10.1016/j.jacl.2010.02.005. Epub 2010 Feb 12.

PMID:
21122635
6.

An algorithm to predict risk of type 2 diabetes in Turkish adults: contribution of C-reactive protein.

Onat A, Can G, Yüksel H, Ayhan E, Dogan Y, Hergenç G.

J Endocrinol Invest. 2011 Sep;34(8):580-6. doi: 10.3275/7323. Epub 2010 Oct 27.

PMID:
21042044
7.

The APOE -219G/T and +113G/C polymorphisms affect insulin resistance among Turks.

Komurcu-Bayrak E, Onat A, Yuzbasiogullari B, Mononen N, Laaksonen R, Kähönen M, Hergenc G, Lehtimäki T, Erginel-Unaltuna N.

Metabolism. 2011 May;60(5):655-63. doi: 10.1016/j.metabol.2010.06.016. Epub 2010 Aug 17.

PMID:
20723945
8.

[Cigarette smoking and metabolic syndrome in Turkish women/Frequency and affecting factors of metabolic syndrome in women older than 20 years of age/Metabolic syndrome: importance and prevention].

Onat A, Hergenç G.

Anadolu Kardiyol Derg. 2010 Aug;10(4):384; author reply 384-6. doi: 10.5152/akd.2010.104. Turkish. No abstract available.

9.

Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk.

Onat A, Hergenç G.

Metabolism. 2011 Apr;60(4):499-512. doi: 10.1016/j.metabol.2010.04.018. Epub 2010 May 23. Review.

PMID:
20580781
10.

High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones.

Onat A, Can G, Hergenç G, Küçükdurmaz Z, Uğur M, Yüksel H.

Cardiology. 2010;115(4):297-306. doi: 10.1159/000312009. Epub 2010 Apr 16.

PMID:
20395681
11.

Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels.

Onat A, Kömürcü-Bayrak E, Can G, Küçükdurmaz Z, Hergenç G, Erginel-Unaltuna N.

Nutrition. 2010 Oct;26(10):975-80. doi: 10.1016/j.nut.2009.09.023. Epub 2010 Jan 29.

PMID:
20116212
12.

[Major influence of dysfunctions of protective serum proteins on cardiometabolic risk among Turks and gender difference].

Onat A, Hergenç G, Can G.

Turk Kardiyol Dern Ars. 2009 Sep;37(6):425-34. Review. Turkish.

13.

Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.

Onat A, Hergenç G, Can G, Kaya Z, Yüksel H.

Metabolism. 2010 May;59(5):628-34. doi: 10.1016/j.metabol.2009.09.006. Epub 2009 Nov 14.

PMID:
19913840
14.

Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks.

Onat A, Hergenç G, Ayhan E, Uğur M, Kaya H, Tuncer M, Can G.

Diabet Med. 2009 Oct;26(10):981-8. doi: 10.1111/j.1464-5491.2009.02814.x.

PMID:
19900229
15.

Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks.

Onat A, Hergenç G, Ayhan E, Uğur M, Can G.

Clin Chem Lab Med. 2009;47(11):1389-94. doi: 10.1515/CCLM.2009.310.

PMID:
19817643
16.

Visceral adipose tissue and body fat mass: predictive values for and role of gender in cardiometabolic risk among Turks.

Onat A, Uğur M, Can G, Yüksel H, Hergenç G.

Nutrition. 2010 Apr;26(4):382-9. doi: 10.1016/j.nut.2009.05.019. Epub 2009 Jul 24.

PMID:
19632090
17.

Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.

Onat A, Can G, Ayhan E, Kaya Z, Hergenç G.

Metabolism. 2009 Oct;58(10):1393-9. doi: 10.1016/j.metabol.2009.05.004. Epub 2009 Jul 1.

PMID:
19570555
18.
19.

Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults.

Komurcu-Bayrak E, Erginel-Unaltuna N, Onat A, Ozsait B, Eklund C, Hurme M, Mononen N, Laaksonen R, Hergenc G, Lehtimäki T.

Atherosclerosis. 2009 Oct;206(2):474-9. doi: 10.1016/j.atherosclerosis.2009.03.030. Epub 2009 Apr 5.

PMID:
19410251
20.

Moderate and heavy alcohol consumption among Turks: long-term impact on mortality and cardiometabolic risk.

Onat A, Hergenç G, Küçükdurmaz Z, Uğur M, Kaya Z, Can G, Yüksel H.

Turk Kardiyol Dern Ars. 2009 Mar;37(2):83-90.

Supplemental Content

Loading ...
Support Center